Pulse Explorer nav.journalClub Débats Tendances Chercheurs Revues

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Accueil Explorer nav.journalClub Tendances

⌘+K

Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure | Synapse

December 8, 2003

View Full Paper

Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure

RNRichard W. NestoGeneral / Preventive / Lipids DBDavid S.H. BellYahoo (United Kingdom)

Robert O. BonowStructural Heart Disease

Key Points

Key points are not available for this paper at this time.

Abstract

HomeCirculationVol. 108, No. 23Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Nesto et al. (Mon,) studied this question.

synapsesocial.com/papers/69fbd7786c3a0c248625dca9 https://doi.org/https://doi.org/10.1161/01.cir.0000103683.99399.7e

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Oral Insulin Sensitizer, Thiazolidinedione, Increases Plasma Vascular Endothelial Growth Factor in Type 2 Diabetic Patients2001 · 58 citations
2Troglitazone Reduces Plasma Leptin Concentration but Increases Hunger in NIDDM Patients1998 · 116 citations
3Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro.1998 · 100 citations
4ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary2001 · 1,920 citations
5Cardiac and Glycemic Benefits of Troglitazone Treatment in NIDDM1997 · 366 citations